Dispersyn Gerrit 4
4 · RXi Pharmaceuticals Corp · Filed Aug 3, 2018
Insider Transaction Report
Form 4
Dispersyn Gerrit
Chief Development Officer
Transactions
- Award
Common Stock
2018-08-01+16,000→ 16,350 total - Award
Stock option (right to buy)
2018-08-01+16,000→ 16,000 totalExercise: $1.79Exp: 2028-08-01→ Common stock (16,000 underlying)
Footnotes (2)
- [F1]Represents shares underlying a restricted stock unit, which shares will vest in four equal annual installments.
- [F2]The stock option will vest in four equal annual installments.